Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Cytokinetics, Incorporated(CYTK) | 853,862 | 911,182 | +57,320 | $46.26M | $48.11M | 8.06% | +$1.85M |
| Protagonist Therapeutics Inc | 1,603,932 | 981,295 | -622,637 | $55.58M | $44.16M | 7.40% | -$11.42M |
| BridgeBio Pharma, Inc.(BBIO) | 1,264,570 | 1,448,470 | +183,900 | $32.03M | $36.88M | 6.18% | +$4.85M |
| Ea Series TrustALPHA ARCH 1 3 ALPHA ARCH 1-3 | 351,482 | 323,382 | -28,100 | $37.90M | $35.23M | 5.90% | -$2.67M |
| Roivant Sciences Ltd.SHS(ROIV) | 4,150,009 | 3,025,450 | -1,124,559 | $43.87M | $34.91M | 5.85% | -$8.95M |
| Immunovant, Inc.(IMVT) | 476,543 | 1,131,707 | +655,164 | $12.58M | $32.26M | 5.41% | +$19.68M |
| Royalty Pharma plcCL A(RPRX) | 1,181,332 | 1,096,666 | -84,666 | $31.15M | $31.02M | 5.20% | -$127.0K |
| Keros Therapeutics, Inc.(KROS) | 548,916 | 445,068 | -103,848 | $25.09M | $25.85M | 4.33% | +$759.6K |
| Ascendis Pharma A/SADR(ASND) | 51,263 | 161,402 | +110,139 | $6.99M | $24.10M | 4.04% | +$17.11M |
| Zura Bio LimitedCL A(ZURA) | 0 | 3,770,649 | +3,770,649 | $0 | $15.31M | 2.57% | +$15.31M |
| Zai Lab LimitedADR(ZLAB) | 22,000 | 532,454 | +510,454 | $381.3K | $12.85M | 2.15% | +$12.47M |
| Kiniksa Pharmaceuticals International, plcCL A(KNSA) | 114,309 | 436,668 | +322,359 | $2.13M | $10.91M | 1.83% | +$8.78M |
| Aa Mission Acquisition CorpCL A | 0 | 1,010,199 | +1,010,199 | $0 | $10.12M | 1.70% | +$10.12M |
| Mineralys Therapeutics, Inc.(MLYS) | 25,366 | 729,401 | +704,035 | $296.8K | $8.83M | 1.48% | +$8.54M |
| Arbutus Biopharma Corporation(ABUS) | 3,289,260 | 2,089,321 | -1,199,939 | $10.16M | $8.04M | 1.35% | -$2.12M |
| Solid Biosciences Inc | 1,420,422 | 1,145,592 | -274,830 | $8.05M | $7.98M | 1.34% | -$69.0K |
| Merus N V | 26,850 | 153,286 | +126,436 | $1.59M | $7.66M | 1.28% | +$6.07M |
| Rezolute, Inc.(RZLT) | 2,063,962 | 1,571,705 | -492,257 | $8.88M | $7.62M | 1.28% | -$1.25M |
| Perceptive Cap Solutions CorCL A CL A ORD SHS | 750,000 | 750,000 | 0 | $7.54M | $7.51M | 1.26% | -$30.0K |
| Xencor, Inc.(XNCR) | 0 | 342,262 | +342,262 | $0 | $6.88M | 1.15% | +$6.88M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 0 | 350,206 | +350,206 | $0 | $6.74M | 1.13% | +$6.74M |
| Anaptysbio Inc | 155,799 | 192,720 | +36,921 | $3.90M | $6.46M | 1.08% | +$2.55M |
| ABIVAX Société AnonymeADS(ABVX) | 27,000 | 521,612 | +494,612 | $356.9K | $6.01M | 1.01% | +$5.65M |
| REGENXBIO Inc.(RGNX) | 2,700 | 569,008 | +566,308 | $31.6K | $5.97M | 1.00% | +$5.94M |
| Biogen Inc.(BIIB) | 0 | 29,625 | +29,625 | $0 | $5.74M | 0.96% | +$5.74M |
| OmniAb, Inc.(OABI) | 712,560 | 1,337,302 | +624,742 | $2.67M | $5.66M | 0.95% | +$2.98M |
| CG Oncology, Inc.(CGON) | 12,850 | 143,104 | +130,254 | $405.7K | $5.40M | 0.91% | +$4.99M |
| Crinetics Pharmaceuticals In | 74,850 | 88,425 | +13,575 | $3.35M | $4.52M | 0.76% | +$1.17M |
| Helix Acquisition Corp IiCL A | 404,138 | 404,138 | 0 | $4.13M | $4.22M | 0.71% | +$92.9K |
| Tectonic Therapeutic, Inc.(TECX) | 356,878 | 127,159 | -229,719 | $5.88M | $3.85M | 0.65% | -$2.02M |
| Iteos Therapeutics Inc | 60,000 | 376,737 | +316,737 | $890.4K | $3.85M | 0.64% | +$2.96M |
| Absci Corporation | 1,698,529 | 1,005,750 | -692,779 | $5.23M | $3.84M | 0.64% | -$1.39M |
| Endeavor Group Hldgs IncCL A | 10,615 | 122,807 | +112,192 | $286.9K | $3.51M | 0.59% | +$3.22M |
| Apogee Therapeutics Inc | 40,875 | 57,183 | +16,308 | $1.61M | $3.36M | 0.56% | +$1.75M |
| Dianthus Therapeutics, Inc.(DNTH) | 0 | 118,738 | +118,738 | $0 | $3.25M | 0.54% | +$3.25M |
| Savara Inc.(SVRA) | 663,598 | 742,634 | +79,036 | $2.67M | $3.15M | 0.53% | +$474.5K |
| Denali Therapeutics Inc.(DNLI) | 38,000 | 101,826 | +63,826 | $882.4K | $2.97M | 0.50% | +$2.08M |
| Grace Therapeutics, Inc.CL A(GRCE) | 0 | 959,571 | +959,571 | $0 | $2.88M | 0.48% | +$2.88M |
| Q32 Bio Inc.(QTTB) | 156,504 | 64,245 | -92,259 | $2.81M | $2.87M | 0.48% | +$57.4K |
| Pliant Therapeutics, Inc.(PLRX) | 10,000 | 246,128 | +236,128 | $107.5K | $2.76M | 0.46% | +$2.65M |
| Geron Corporation(GERN) | 90,000 | 557,159 | +467,159 | $381.6K | $2.53M | 0.42% | +$2.15M |
| Pieris Pharmaceuticals Inc | 0 | 144,641 | +144,641 | $0 | $2.40M | 0.40% | +$2.40M |
| Vir Biotechnology, Inc.(VIR) | 110,000 | 319,185 | +209,185 | $979.0K | $2.39M | 0.40% | +$1.41M |
| Cellectar Biosciences, Inc.(CLRB) | 682,094 | 1,022,161 | +340,067 | $1.71M | $2.19M | 0.37% | +$482.2K |
| Alkermes plcSHS(ALKS) | 196,577 | 74,431 | -122,146 | $4.74M | $2.08M | 0.35% | -$2.65M |
| Revolution Medicines, Inc.(RVMD) | 0 | 44,351 | +44,351 | $0 | $2.01M | 0.34% | +$2.01M |
| Spdr Ser TrBLOOMBERG 1 3 MO ST STR BLO 1 ETF | 32,500 | 21,786 | -10,714 | $2.98M | $2.00M | 0.34% | -$982.7K |
| Alector Inc | 195,311 | 428,802 | +233,491 | $886.7K | $2.00M | 0.33% | +$1.11M |
| Teva Pharmaceutical Industries LimitedADS(TEVA) | 103,121 | 108,171 | +5,050 | $1.68M | $1.95M | 0.33% | +$273.5K |
| KALA BIO, Inc.(KALA) | 306,067 | 306,067 | 0 | $2.17M | $1.74M | 0.29% | -$425.4K |
| Korro Bio, Inc.(KRRO) | 7,210 | 49,451 | +42,241 | $244.2K | $1.65M | 0.28% | +$1.41M |
| Aldeyra Therapeutics, Inc.(ALDX) | 0 | 302,212 | +302,212 | $0 | $1.63M | 0.27% | +$1.63M |
| Instil Bio, Inc.(TIL) | 0 | 23,707 | +23,707 | $0 | $1.60M | 0.27% | +$1.60M |
| Ares Acquisition Corp IiCL A | 0 | 138,966 | +138,966 | $0 | $1.51M | 0.25% | +$1.51M |
| BioNTech SEADS(BNTX) | 0 | 10,000 | +10,000 | $0 | $1.19M | 0.20% | +$1.19M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 4,800 | 23,457 | +18,657 | $211.1K | $1.18M | 0.20% | +$971.6K |
| enVVeno Medical Corporation(NVNO) | 201,728 | 348,263 | +146,535 | $1.06M | $1.17M | 0.20% | +$111.1K |
| Vaxcyte, Inc.(PCVX) | 12,250 | 10,097 | -2,153 | $925.0K | $1.15M | 0.19% | +$228.8K |
| Disc Medicine, Inc.(IRON) | 0 | 22,564 | +22,564 | $0 | $1.11M | 0.19% | +$1.11M |
| Xenon Pharmaceuticals Inc.(XENE) | 4,700 | 27,903 | +23,203 | $183.3K | $1.10M | 0.18% | +$915.3K |
| Beam Therapeutics Inc.(BEAM) | 72,800 | 43,900 | -28,900 | $1.71M | $1.08M | 0.18% | -$630.2K |
| Nuvalent Inc | 0 | 10,442 | +10,442 | $0 | $1.07M | 0.18% | +$1.07M |
| CytomX Therapeutics, Inc.(CTMX) | 572,170 | 903,959 | +331,789 | $698.0K | $1.07M | 0.18% | +$368.6K |
| Avadel Pharmaceuticals Plc | 0 | 80,900 | +80,900 | $0 | $1.06M | 0.18% | +$1.06M |
| iBio, Inc.CON NEW(IBIO) | 570,000 | 476,212 | -93,788 | $1.20M | $1.06M | 0.18% | -$145.5K |
| Pfizer Inc.(PFE) | 39,950 | 35,950 | -4,000 | $1.12M | $1.04M | 0.17% | -$77.4K |
| Endeavour Silver Corp.(EXK) | 600 | 15,200 | +14,600 | $25.4K | $1.04M | 0.17% | +$1.01M |
| Kezar Life Sciences Inc COM NEW | 0 | 1,338,273 | +1,338,273 | $0 | $1.03M | 0.17% | +$1.03M |
| Bicara Therapeutics Inc | 0 | 40,440 | +40,440 | $0 | $1.03M | 0.17% | +$1.03M |
| Astria Therapeutics Inc | 138,158 | 93,284 | -44,874 | $1.26M | $1.03M | 0.17% | -$230.2K |
| Eli Lilly and Company(LLY) | 0 | 1,150 | +1,150 | $0 | $1.02M | 0.17% | +$1.02M |
| Spero Therapeutics, Inc.(SPRO) | 918,929 | 743,459 | -175,470 | $1.19M | $996.2K | 0.17% | -$198.4K |
| Intra-Cellular Therapies Inc | 0 | 13,400 | +13,400 | $0 | $980.5K | 0.16% | +$980.5K |
| Agios Pharmaceuticals, Inc.(AGIO) | 0 | 21,300 | +21,300 | $0 | $946.4K | 0.16% | +$946.4K |
| Revance Therapeutics Inc | 0 | 182,166 | +182,166 | $0 | $945.4K | 0.16% | +$945.4K |
| Mirum Pharmaceuticals, Inc.(MIRM) | 0 | 24,100 | +24,100 | $0 | $939.9K | 0.16% | +$939.9K |
| Regeneron Pharmaceuticals, Inc.(REGN) | 0 | 871 | +871 | $0 | $915.6K | 0.15% | +$915.6K |
| McKesson Corporation(MCK) | 0 | 1,850 | +1,850 | $0 | $914.7K | 0.15% | +$914.7K |
| Cullinan Therapeutics, Inc.(CGEM) | 53,261 | 54,358 | +1,097 | $928.9K | $910.0K | 0.15% | -$18.9K |
| Sarepta Therapeutics, Inc.(SRPT) | 4,450 | 7,100 | +2,650 | $703.1K | $886.7K | 0.15% | +$183.6K |
| Tarsus Pharmaceuticals, Inc.(TARS) | 0 | 25,900 | +25,900 | $0 | $851.9K | 0.14% | +$851.9K |
| Climb Bio, Inc.(CLYM) | 97,695 | 163,443 | +65,748 | $694.6K | $831.9K | 0.14% | +$137.3K |
| Agriculture & Nat Sol Acq CoCL A SHS CL A | 0 | 80,362 | +80,362 | $0 | $831.7K | 0.14% | +$831.7K |
| Avangrid Inc | 23,000 | 23,000 | 0 | $817.2K | $823.2K | 0.14% | +$6.0K |
| Keen Vision Acquisition CorporationUNIT 99 99 9999(KVACF) | 75,000 | 75,000 | 0 | $792.8K | $804.8K | 0.13% | +$12.0K |
| PTC Therapeutics, Inc.(PTCT) | 0 | 20,000 | +20,000 | $0 | $742.0K | 0.12% | +$742.0K |
| Day One Biopharmaceuticals I COM | 35,100 | 53,111 | +18,011 | $483.7K | $739.8K | 0.12% | +$256.2K |
| Context Therapeutics Inc.(CNTX) | 645,161 | 373,835 | -271,326 | $1.29M | $732.7K | 0.12% | -$560.8K |
| Silence Therapeutics plcADS(SLN) | 40,290 | 40,290 | 0 | $765.5K | $732.5K | 0.12% | -$33.0K |
| Kiora Pharmaceuticals, Inc.(KPRX) | 172,596 | 196,551 | +23,955 | $724.9K | $719.4K | 0.12% | -$5.5K |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 107,306 | 220,906 | +113,600 | $203.9K | $715.7K | 0.12% | +$511.9K |
| Powerschool Holdings IncCL A | 0 | 30,000 | +30,000 | $0 | $684.3K | 0.11% | +$684.3K |
| Akero Therapeutics Inc | 25,507 | 23,007 | -2,500 | $598.4K | $660.1K | 0.11% | +$61.7K |
| Aura Biosciences, Inc.(AURA) | 203,237 | 73,663 | -129,574 | $1.54M | $656.3K | 0.11% | -$880.1K |
| Nabors Energy Transition CorCL A | 0 | 59,900 | +59,900 | $0 | $638.5K | 0.11% | +$638.5K |
| Option Care Health, Inc.(OPCH) | 12,000 | 20,000 | +8,000 | $332.4K | $626.0K | 0.10% | +$293.6K |
| Janux Therapeutics, Inc.(JANX) | 7,891 | 13,000 | +5,109 | $330.6K | $590.6K | 0.10% | +$260.0K |
| Kura Oncology, Inc.(KURA) | 0 | 30,000 | +30,000 | $0 | $586.2K | 0.10% | +$586.2K |
| Tmt Acquisition CorpSHS | 50,000 | 50,000 | 0 | $549.0K | $562.0K | 0.09% | +$13.0K |
| Kymera Therapeutics, Inc.(KYMR) | 50,626 | 11,856 | -38,770 | $1.51M | $561.1K | 0.09% | -$950.0K |